Melanoma tumour-infiltrating T-lymphocyte therapy heralds the era of cell-based immunotherapies for solid tumours
British Journal of Dermatology · 2024
DOI: 10.1093/bjd/ljae126 ↗Kurz gefasst
Editorial in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Ronan Talty und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Dermatology. Hauptthemen laut MEDLINE: Melanoma, Lymphocytes, Tumor-Infiltrating, Skin Neoplasms. Die Arbeit nennt 15 Literaturangaben. Gefördert von: Dermatology Foundation, NIH, American Skin Association.
Abstract (Originalsprache)
Ronan Talty, Rhys Richmond, Goran Micevic; Melanoma TIL therapy commences era of cell-based immunotherapies, British Journal of Dermatology, , ljae126, https://
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Departments of Dermatology.
- Pathology.
- Immunobiology, Yale School of Medicine, New Haven, CT, USA.
ORCID-Profile: Ronan Talty, Rhys Richmond, Goran Micevic
Förderung
- Dermatology Foundation
- NIH
- American Skin Association
- Skin Cancer Foundation
Zitieren
APA
Talty, R., Richmond, R., & Micevic, G. (2024). Melanoma tumour-infiltrating T-lymphocyte therapy heralds the era of cell-based immunotherapies for solid tumours. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae126
Vancouver
Talty R, Richmond R, Micevic G. Melanoma tumour-infiltrating T-lymphocyte therapy heralds the era of cell-based immunotherapies for solid tumours. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae126
BibTeX
@article{Talty2024,
author = {Talty, Ronan and Richmond, Rhys and Micevic, Goran},
title = {Melanoma tumour-infiltrating T-lymphocyte therapy heralds the era of cell-based immunotherapies for solid tumours},
journal = {British Journal of Dermatology},
year = {2024},
doi = {10.1093/bjd/ljae126}
}
EUVIMED